Products with Immunomodulators bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN3731 | Dihydrobonducellin |
| 1. Dihydrobonducellin has immunopharmacological activity, it significantly inhibits the production of IL-2 and IFN-gamma in activated PBMC in a concentration-dependent manner. | |
| BCN3841 | Inosine |
| Inosine, an endogenous purine nucleoside, has immunomodulatory, neuroprotective, and analgesic properties.Inosine is a cardiotonic agent, can treat cardiac disorders.Inosine can to be capable of forming base pairs with Adenine HFN72-P, Cytosine HDR44-O or Uracil BTP40-U thus contributing to genetic code degeneracy by causing stable mispairings. | |
| BCN3847 | Platycodin D2 |
| 1. Platycodin D2 , a less hemolytic saponin, can improve specific cellular and humoral responses to hepatitis B surface antigen in mice. 2. Platycodin D2 could be safely used as adjuvant eliciting Th1 and Th2 immune responses. 3. Polygalacin D2 exhibits significant inhibition on the proliferation of five kinds of cultured human tumor cell lines, i. e., A549 (non-small cell lung), SK-OV-3 (ovary), SK-MEL-2 (melanoma), XF498 (central nerve system) and HCT-15 (colon), in vitro. | |
| BCN3865 | Purpureaside C |
| 1. Purpureaside C has significant proinflammatory, antimicrobial and immunomodulating effects. | |
| BCN4059 | Cyclo(Gly-L-Pro) |
| Cyclo(Gly-(L)-Pro) shows immunostimulatory properties. Cyclo(Gly-l-Pro) exhibits potent inhibition of TNF-α release with the IC50 values of 4.5 ug/mL, respectively, it also exhibits significant diminution of IL-1β and IL-6 mRNA-expression levels and NO production. | |
